Turkey Company Roundup: Pricing, OTC Policies Attacked
This article was originally published in PharmAsia News
Roche Turkey has warned the government about the consequences of its pricing policies, and Turkey’s OTC pricing practices have also come in for criticism. Meanwhile, Hacettepe University and Keyman Ilac have signed a vaccine deal and GENKORD has started manufacturing Factor VIII locally for the first time in Turkey.
Register for our free email digests: